Download Infectious Diseases

Earn up to:
35.75 AMA PRA Category 1 Credits™
2 Credits Risk Management Study
Practical, focused education that ensures
attendees are current with the updates
and clinical best practices that are now
producing the best patient outcomes
Infectious
Diseases
in Adults
May 2–6
2016
Boston, MA
This program is among the highest-rated Harvard Medical School CME courses
Prevention
2016 updates for diagnosis and treatment of
common, complex, and emerging infectious diseases
Detection
Guidance to prevent and detect infections in
travelers and immigrants
Diagnosis
Instruction for detecting and addressing rare and
“don’t-miss” infectious diseases
Treatment
Criteria and strategies for optimal clinical decision
making
Best practices for safety and practice improvement
Register at ID.HMSCME.com
Course Director
Nesli Basgoz, MD
Associate Chief and Clinical Director, Division of Infectious Diseases, and
Firm Chief, Fuller Albright Firm, Department of Medicine, Massachusetts
General Hospital; Associate Professor, Harvard Medical School
Course Co-Directors
Stephen B. Calderwood, MD
Chief, Division of Infectious Diseases; Vice-Chair, Department of Medicine;
and Director of Undergraduate Medical Education, Massachusetts
General Hospital; Morton N. Swartz, MD Academy Professor of Medicine
(Microbiology and Immunobiology), Harvard Medical School
Rajesh T. Gandhi, MD
Director, HIV Clinical Services and Education, and Physician,
Massachusetts General Hospital (MGH); Leader of the MGH Clinical
Research Site in the AIDS Clinical Trials Group; Director of the Harvard
University Center for AIDS Research Clinical Core; Associate Professor of
Medicine, Harvard Medical School
Sandra B. Nelson, MD
Director, Musculoskeletal Infectious Disease and OPAT (Outpatient
Parenteral Antibiotic Therapy) Programs, Division of Infectious Diseases,
Massachusetts General Hospital; Assistant Professor of Medicine,
Harvard Medical School
Upon completion of this course,
participants will be able to:
• Improve knowledge and clinical
skills in Infectious Diseases
• Utilize the latest strategies for the
prevention, recognition, diagnosis,
and treatment of important
syndromes in Infectious Diseases
• Determine a differential diagnosis
and initiate an appropriate
diagnostic evaluation for the major
infectious disease-related problems
in clinical practice
• Analyze relevant areas of basic
science to enable both the
comprehension and the application
of future discoveries to patient care
Course Description
Guest Faculty
Angela M. Caliendo, MD, PhD
Professor and Vice Chair, Department of Medicine, Warren Alpert Medical
School of Brown University
Jane E. Koehler, MA, MD
Professor of Medicine, Division of Infectious Diseases, University of
California at San Francisco
Dimitrios Kontoyiannis, MD, ScD, FACP, FIDSA
Frances King Black Endowed Professor, Infectious Diseases, and
Deputy Head, Division of Internal Medicine, The University of Texas MD
Anderson Cancer Center
Vincent J. Quagliarello, MD
Professor of Medicine and Clinical Chief, Infectious Diseases Section, Yale
University School of Medicine
Daniel J. Sexton, MD
Professor, Department of Medicine, Division of Infectious Diseases, and
Director, Duke Infectious Control Outreach Network, Duke University
Medical Center
Allan R. Tunkel, MD, PhD, MACP
Associate Dean for Medical Education, and Professor of Medicine and
Medical Science, Warren Alpert Medical School of Brown University
Harvard Medical School Faculty
Kevin L. Ard, MD, MPH
Miriam B. Barshak, MD
Nesli Basgoz, MD
Stephen B. Calderwood, MD
Benjamin T. Davis, MD
Donna Felsenstein, MD
Rajesh T. Gandhi, MD
Sarah Hammond, MD
Howard M. Heller, MD, MPH
Martin S. Hirsch, MD
Elizabeth Hohmann, MD
Learning Objectives
David C. Hooper, MD
Rocio Hurtado, MD, DTM&H
Arthur Kim, MD
Camille Nelson Kotton, MD
Alyssa R. Letourneau, MD, MPH
Sandra B. Nelson, MD
Eric S. Rosenberg, MD
Edward T. Ryan, MD
Paul E. Sax, MD
Erica S. Shenoy, MD, PhD
Sigal Yawetz, MD
Infectious Diseases in Adults provides
state-of-the-art information in the prevention, diagnosis, and management
of important infectious diseases. This
highly rated course focuses on major
clinical syndromes as well as management controversies in infectious
disease. Topics with major impact on
clinical practice are emphasized, including: antibiotic resistance, sexually
transmitted diseases, endocarditis,
vaccination, hospital epidemiology,
infections in pregnancy, zoonotic
infections, parasitology, tuberculosis,
molecular diagnostics, and pandemic
influenza. The care of the patient with
HIV/AIDS is discussed in detail: the
biology of the infection, epidemiology, antiviral therapies, ambulatory
management, and the prevention and
treatment of opportunistic infections.
The management of infections in
immunocompromised hosts will be reviewed. Emphasis is placed on recent
developments, including the newer
antibiotics and vaccines, antiviral and
antiparasitic agents, new diagnostic
techniques, and recommendations for
prophylaxis in travelers.
Register at ID.HMSCME.com
Course Highlights
Clinical Decision
Making
Hear directly from world-renowned
specialists and master clinicians on
their approach and decision-making
criteria for:
Common Infectious Diseases:
Updates in Prevention, Diagnosis
and Treatment
Updates that ensure you are current with new strategies,
best practices and 2016 guidelines for addressing:
• Infections in immunocompromised hosts
• Skin and soft tissue infections
• Endocarditis, urinary tract infections, C. difficile colitis,
and tuberculosis
• Bone and joint infections
• Sexually transmitted infections, including new
guidelines
• ENT infections
• Pneumonia
• Lyme and other tick-borne diseases
• HIV infection and its complications
• PEP (Post-Exposure Prophylaxis) and PrEP
(Pre-Exposure Prophylaxis) to prevent HIV infection
• Vaccinations
• Hepatitis C
Challenging, Rare, and Emerging
Infectious Diseases
Comprehensive updates on:
• Zika, Ebola, MERS, and other emerging infectious
diseases
• Infections in travelers and immigrants
• Zoonoses in the US—the old and the new
• Re-emergence of vaccine-preventable diseases in the
United States
• Non-tuberculous (“atypical”) mycobacteria
• Eye infections: what you need to know
• Antimicrobial usage
• Selecting and utilizing newer
diagnostic tests for infectious
disease
• Diagnosing the low-probability but
high-impact infections
• Early detection of life-threatening
infections
• Determining when to hospitalize vs.
treat as an outpatient
• Rational empiric antimicrobial
therapy of serious infections:
when and how to start, and when
to narrow or stop
• Is it viral or bacterial? Key factors to
consider
Safety, Quality, and
Practice Improvement
Special sessions on safety, quality,
and value added by ID specialists
• Antimicrobial stewardship
• Infection control
• Early inpatient ID consultations to
reduce mortality, length of stay,
and costs
• Outpatient Parenteral Antibiotic
Therapy (OPAT): best practices in
design and operation of successful
OPAT programs
• ID for hospital medicine practices
AGENDA
Sunday, May 1
7:00 pm – 9:00 pm
Pre-registration
Monday, May 2
7:00 am - 8:00 am
Registration (continental breakfast served)
8:00 am - 8:20 am
Introduction and Road Map Nesli Basgoz, MD
Session 1 • 8:20 am – 12:10 pm
Moderator: Dr. Nesli Basgoz
Review of Major Antimicrobial Classes and Empiric
Therapy: 2016 Alyssa R. Letourneau, MD, MPH
Q & A Session
Update on New Antibiotics for Resistant Gram
Positive Infections David C. Hooper, MD
Q & A Session
Tuesday, May 3
6:45 am - 8:30 am
Continental breakfast served
7:00 am - 7:50 am
Concurrent Breakouts:
1. ID Updates for the Hospital Medicine Specialist
Miriam B. Barshak, MD
2. OPAT for ID Specialists
Sandra B. Nelson, MD
Session 3 • 8:00 am – 12:15 pm
Moderator: Dr. Sandra B. Nelson
Skin and Soft Tissue Infections: Diagnostic and
Treatment Approaches Sandra B. Nelson, MD
Q & A Session
Eye and ENT Infections: What You Need to Know
Miriam B. Barshak, MD
Q & A Session
Coffee Break
Coffee Break
Meningitis Vincent J. Quagliarello, MD
Update on New Antibiotics for Resistant Gram
Negative Infections David C. Hooper, MD
Q & A Session
Q & A Session
New Approaches to Infection Control and
Antimicrobial Stewardship Erica S. Shenoy, MD, PhD
Q & A Session
12:10 pm - 1:30 pm
Lunch Break
Session 2 • 1:30 pm – 5:05 pm
Moderator: Dr. Nesli Basgoz
Cases in Sepsis and Highly Resistant Bacterial
Infections Alyssa R. Letourneau, MD, MPH
Q & A Session
Treatment of Herpes and Influenza Virus Infections
Martin S. Hirsch, MD
Q & A Session
Coffee Break
Advances in Hepatitis C Monoinfection
Arthur Kim, MD
Q & A Session
Bites, Scratches, and Rabies Nesli Basgoz, MD
Q & A Session
Pneumonia Benjamin T. Davis, MD
Q & A Session
12:15 pm - 1:30 pm
Lunch Break
Session 4 • 1:30 pm – 5:30 pm
Moderator: Dr. Rajesh T. Gandhi
Encephalitis and Healthcare-Associated CNS
Infections: Guidelines and Best Practices
Allan R. Tunkel, MD, PhD, MACP
Q & A Session
Updates in Endocarditis including New Guidelines
Stephen B. Calderwood, MD
Q & A Session
Coffee Break
Clostridium Difficile Infection including Recurrent
and Refractory Disease and Novel Approaches
Elizabeth Hohmann, MD
Q & A Session
Sexually Transmitted Infections: Clinical Pearls and
New Treatment Guidelines Donna Felsenstein, MD
DISCLOSURE POLICY: Harvard Medical School (HMS) adheres to all ACCME Essential Areas, Standards, and Policies. It is HMS’s
policy that those who have influenced the content of a CME activity (e.g., planners, faculty, reviewers, and others) disclose all
relevant financial relationships with commercial entities so that HMS may identify and resolve any conflicts of interest prior to the
activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the
activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses
of products during their presentations.
AGENDA
Wednesday, May 4
6:45 am - 8:30 am Continental breakfast served
Session 5 • 8:00 am – 12:30 pm
Moderator: Dr. Rajesh T. Gandhi
Challenges in Acute HIV Infection and HIV Testing Eric S. Rosenberg, MD
Q & A Session
HIV Management 2016: Initial Approach and Treatment Rajesh T. Gandhi, MD
Q & A Session
Recent Advances in HIV and What’s on the Horizon Rajesh T. Gandhi, MD
Q & A Session
Coffee Break
Immunocompromised Host and Infections in Hematologic Malignancies Sarah Hammond, MD
Q & A Session
Update on Antifungal Diagnostics and Therapy Dimitrios Kontoyiannis, MD, ScD, FACP, FIDSA
Q & A Session
12:30 pm - 1:45 pm Lunch Break
Session 6 • 1:45 - 5:30
Concurrent Specialty Sessions
Session 1: HIV
Session 2:
Non-HIV Immunocompromised Host
Moderator: Dr. Rajesh T. Gandhi
Continuing Challenges in HIV-Associated
Opportunistic Infections Nesli Basgoz, MD
Q & A Session
Pre- and Post-Exposure Prophylaxis for HIV
Kevin L. Ard, MD, MPH
Q & A Session
Coffee Break
Advances in the Prevention and Treatment of HPV
Disease Benjamin T. Davis, MD
Q & A Session
Rapidly Evolving Landscape of HIV/HCV
Coinfection
Arthur Kim, MD
Q & A Session
Our Most Difficult HIV Cases and What We Learned
from Them — Panel Discussion
Moderated by Rajesh T. Gandhi, MD
Q & A Session
5:30 pm - 7:15 pm
Moderator: Dr. Sandra B. Nelson
Infections in Stem Cell Transplant Recipients
Sarah Hammond, MD
Q & A Session
Infections in Solid Organ Transplant Recipients
Camille Nelson Kotton, MD
Q & A Session
Coffee break
Infections in Patients on Immunomodulatory
Therapy
Camille Nelson Kotton, MD
Q & A Session
My Most Difficult Cases in Immunocompromised
Hosts and What I Learned from Them
Dimitrios Kontoyiannis, MD, ScD, FACP, FIDSA
Q & A Session
Reception for all course participants
Network with your colleagues and course faculty
Program changes/substitutions may be made without notice.
To view the most up-to-date version of the course program, please visit the course website.
AGENDA
Thursday, May 5
6:45 am - 8:30 am
Continental breakfast served
Friday, May 6
6:45 am - 8:00 am
Continental breakfast served
7:00 am - 7:50 am
Breakout Session: Challenging ID Cases from
Course Participants
Sandra B. Nelson, MD
Curbside Consults Paul E. Sax, MD
Q & A Session
Q & A Session
Session 7 • 8:00 am – 12:15 pm
Moderator: Dr. Nesli Basgoz
ID Images: An Interactive Case-Based Discussion
Rajesh T. Gandhi, MD
Q & A Session
Tuberculosis Update Rocio Hurtado, MD, DTM&H
Q & A Session
Nontuberculous Mycobacteria and Bronchiectasis
Nesli Basgoz, MD
Q & A Session
Coffee Break
Native Bone and Joint Infections: Age-Old
Problems and New Guidelines
Sandra B. Nelson, MD
Q & A Session
Orthopedic Device Infections
Sandra B. Nelson, MD
Q & A Session
12:15 pm - 1:30 pm
Lunch Break
Session 8 • 1:30 pm – 5:15 pm
Moderator: Dr. Sandra B. Nelson
Tropical Medicine and Parasitology
Edward T. Ryan, MD
Q & A Session
Immunizations and Travel Medicine in 2016
Edward T. Ryan, MD
Q & A Session
Coffee Break
Ehrlichial and Rickettsial Infections
Daniel J. Sexton, MD
Q & A Session
Lyme and Other Tick-Borne Illnesses: What You
Need to Know
Howard M. Heller, MD, MPH
Q & A Session
Session 9 • 8:00 am – 12:30 pm
Moderator: Dr. Nesli Basgoz
New and Emerging Viruses (including Ebola)
Martin S. Hirsch, MD
Q & A Session
Urinary Tract Infections: The Common and the
Complicated Sigal Yawetz, MD
Q & A Session
Coffee Break
Zoonoses Jane E. Koehler, MD
Q & A Session
Update on Molecular Diagnostics for Infectious
Diseases Angela M. Caliendo, MD, PhD
Q & A Session
12:30 pm Adjourn
Accreditation
The Harvard Medical School is accredited by the
Accreditation Council for Continuing Medical Education to
provide continuing medical education for physicians.
The Harvard Medical School designates this live activity
for a maximum of 35.75 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with
the extent of their participation in the activity.
RISK MANAGEMENT
This activity meets the criteria of the Massachusetts
Board of Registration in Medicine for 2.0 credits of Risk
Management Study. Please check your individual state
licensing board requirements before claiming these credits.
INTERNATIONAL ACCREDITATIONS
The Royal College of Physicians and Surgeons of Canada
recognizes conferences and workshops held outside of
Canada that are developed by a university, academy,
hospital, specialty society or college as accredited group
learning activities.
Through an agreement between the American Medical
Association and the European Union of Medical Specialists,
physicians may convert AMA PRA Category 1 Credit™
to an equivalent number of European CME Credits®
(ECMECs®). Information on the process of converting AMA
PRA Category 1 Credits™ to ECMECs® can be found at:
www.eaccme.eu.
ACGME Competencies
This course is designed to meet the following Accreditation
Council of Graduate Medical Education competencies:
patient care, medical knowledge, and interpersonal and
communications skills.
Infectious Diseases in Adults 2016
Course Tuition
(Course #732580-1602)
Register online at ID.HMSCME.com
Physicians
Allied Health Professionals
Residents and Fellows in Training
Tuition
Register on or before
March 31, 2016
$1,345
$1,245
(Save $100)
$1,095
$995
(Save $100)
$895
Fees shown in USD. Course tuition includes all sessions, the course syllabus on a flash drive, continental breakfast,
morning and afternoon refreshments, and a special reception on Wednesday evening.
When you register for the course, you can indicate that you would like one hard copy of the two-volume syllabus,
in addition to the flash drive, at an additional cost of $50.
Registration, Payment, Confirmation and Refund Policy
Registrations for Harvard Medical School CME programs are made via our secure online registration system.
To register for this course, please visit the course website.
At the end of the registration process, a $5 processing fee will be added to your registration, and you will have the
choice of paying by check or credit card (Visa, MasterCard, or American Express). If you are paying by check, the
online registration system will provide you with instructions and a printable form for remitting your course fees by
check. Postal, telephone, fax, and cash-payment registrations are not accepted.
Upon receipt of your paid registration, an email confirmation from the HMS DCE office will be sent to you. Be sure
to include an email address that you check frequently. Your email address is used for critical information, including
registration confirmation, evaluation, and certificate. Refunds, less an administrative fee of $75, will be issued for
all cancellations received two weeks prior to the start of the course. Refund requests must be received by postal
mail, email, or fax. No refund will be issued should cancellation occur less than two weeks prior. “No shows” are
subject to the full course fee and no refunds will be issued once the conference has started.
VENUE
The Fairmont Copley Plaza Hotel
138 St. James Avenue
Boston, Massachusetts
+1 617-267-5300
ACCOMMODATIONS
A limited number of rooms have been reserved at the Fairmont Copley Plaza Boston until April 9, 2016. When you
call the Global Reservations Centre at 1-800-441-1414 to make a room reservation, please specify that you are
enrolled in this activity to receive the reduced room rate.
Please do not make non-refundable travel arrangements until you have received an email from the HMS
DCE office confirming your paid registration.
INQUIRIES
Call 617-384-8600 Mon-Fri 9am – 5pm EST. Send e-mail to [email protected].
Register at ID.HMSCME.com